TGF-beta1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures

Y Zhu1, B Ahlemeyer, E Bauerbach

  • 1Institut für Pharmakologie und Toxikologie, Philipps-Universität Marburg, Ketzerbach 63, D-35032, Marburg, Germany. zhu@mailer.uni-marburg.de

Insights

Transforming Growth Factor-beta1 (TGF-beta1) prevents neuronal apoptosis and inhibits caspase-3 activation in rat hippocampal cultures. This neuroprotective effect was observed after staurosporine treatment.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Apoptosis, or programmed cell death, is a critical process in neuronal development and survival.
  • Transforming Growth Factor-beta1 (TGF-beta1) has varied effects on apoptosis depending on cell type and experimental context.
  • Neuronal apoptosis is implicated in various neurological disorders.

Purpose of the Study:

  • To investigate the potential of TGF-beta1 to prevent apoptosis in rat primary hippocampal neurons.
  • To determine if TGF-beta1 can inhibit caspase-3 activation induced by staurosporine.
  • To elucidate the role of TGF-beta1 in neuronal protection against apoptotic stimuli.

Main Methods:

  • Primary hippocampal cultures from rats were treated with staurosporine to induce apoptosis.
  • Cells were co-treated with varying concentrations of TGF-beta1 (0.1, 1, and 10 ng/ml).
  • Neuronal damage was assessed using trypan blue exclusion, Hoechst 33258 nuclear staining, and TUNEL assay.
  • Caspase-3 activation was measured via activity assays and Western blotting.

Main Results:

  • TGF-beta1 at 1 and 10 ng/ml significantly reduced neuronal damage and apoptosis following staurosporine treatment.
  • Lower concentration (0.1 ng/ml) of TGF-beta1 did not show significant protective effects.
  • TGF-beta1 (1 and 10 ng/ml) markedly inhibited staurosporine-induced caspase-3 activation at both activity and protein levels.

Conclusions:

  • TGF-beta1 exhibits significant neuroprotective properties against staurosporine-induced apoptosis in hippocampal neurons.
  • The neuroprotection is mediated by the inhibition of caspase-3 activation.
  • These findings highlight TGF-beta1 as a potential therapeutic agent for conditions involving neuronal apoptosis.